AR038208A1 - ORTIALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF MITIGLINIDA - Google Patents

ORTIALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF MITIGLINIDA

Info

Publication number
AR038208A1
AR038208A1 ARP030100179A ARP030100179A AR038208A1 AR 038208 A1 AR038208 A1 AR 038208A1 AR P030100179 A ARP030100179 A AR P030100179A AR P030100179 A ARP030100179 A AR P030100179A AR 038208 A1 AR038208 A1 AR 038208A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
ortially
mitiglinida
dispersable
mitiglinide
Prior art date
Application number
ARP030100179A
Other languages
Spanish (es)
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR038208A1 publication Critical patent/AR038208A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Abstract

Composición farmacéutica sólida dispersable oralmente de mitiglinida que contiene mitiglinida o una de sus sales farmacéuticamente aceptables, y gránulos que consisten en lactosa y almidón cosecados.Orally dispersible solid pharmaceutical composition of mitiglinide containing mitiglinide or a pharmaceutically acceptable salt thereof, and granules consisting of harvested lactose and starch.

ARP030100179A 2002-01-23 2003-01-22 ORTIALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF MITIGLINIDA AR038208A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200794A FR2834892B1 (en) 2002-01-23 2002-01-23 ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF MITIGLINIDE

Publications (1)

Publication Number Publication Date
AR038208A1 true AR038208A1 (en) 2005-01-05

Family

ID=27589558

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030100179A AR038208A1 (en) 2002-01-23 2003-01-22 ORTIALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF MITIGLINIDA

Country Status (3)

Country Link
AR (1) AR038208A1 (en)
FR (1) FR2834892B1 (en)
WO (1) WO2003061650A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1665499A (en) * 2002-06-28 2005-09-07 橘生药品工业株式会社 Drug composition for prevention or inhibition of advance of diabetic complication
EP2050448A4 (en) * 2006-08-08 2012-01-04 Kissei Pharmaceutical Oral disintegrating tablet having masked bitter taste and method for production thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506276C1 (en) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direct tableting
ATE253899T1 (en) * 1994-01-31 2003-11-15 Yamanouchi Pharma Co Ltd INTRAORALLY SOLUBLE MOLDING AND METHOD FOR THE PRODUCTION THEREOF
FR2765578B1 (en) * 1997-07-03 1999-09-10 Adir PROCESS FOR THE PREPARATION OF A SUBSTITUTED PERHYDROISOINDOLE
ATE371439T1 (en) * 2000-07-27 2007-09-15 Roquette Freres GRANULES CONSISTING OF STARCH AND LACTOSE

Also Published As

Publication number Publication date
FR2834892B1 (en) 2004-02-27
WO2003061650A1 (en) 2003-07-31
FR2834892A1 (en) 2003-07-25

Similar Documents

Publication Publication Date Title
AR038207A1 (en) ORIGINALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF AGOMELATINE
NO20052855D0 (en) Phosphonoxycinazoline derivatives and their pharmaceutical use.
NO20045434L (en) A combination of an NMDA antagonist and acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
ZA200501677B (en) Hydantoin derivatives and their use as TACE inhibitors.
CL2004001174A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING: 1- (4-FLUOROPHENYL) -3 (R) - [3- (4-FLUOROPHENYL) -3 (S) -HYDROXIPROPIL] -4 (S) - (4-HYDROXIFENYL) -2-ACETIDINONE ( EZETIMIBA) AND EXCIPIENTS; AND ITS USE IN THE TREATMENT AND / OR PREVENTION OF ATEROSCLEROSIS, HIPERCOLESTEROLEMIA, DAY
NO20052469D0 (en) Inhibitors of II-beta-hydroxysteroid dehydrogenase type 1 and type 2.
NO20042635L (en) 5-Sulfanyl-HH-1,2,4-triazole derivatives and their use as medicine
NO20053356D0 (en) Aminindazole derivatives and their use as kinase inhibitors.
NO20042161L (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
NO20024528L (en) Protease inhibitor, pharmaceutical composition and use of the compound
IL152916A0 (en) Heteroaryl-phenyl heterobicyclic factor xa inhibitors
WO2003048081A3 (en) Glycinamides as factor xa inhibitors
EE200300311A (en) Phthalazinone-piperidine derivatives, their use and medicine
DE60209929D1 (en) SUCCINATE OF 5,8,14-TRIAZATETRACYCLOÄ10.3.1.0 2,11 .0 4,9 Ü-HEXADECA-2 (11), 3,5,7,9, -PENTAES AND PHARMACEUTICAL COMPOSITIONS
SE0101932D0 (en) Pharmaceutical combinations
AR038305A1 (en) ORGANALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF PERINDOPRIL
AR038206A1 (en) IVABRADINA DISPERSABLE PHARMACEUTICAL COMPOSITION
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
WO2005007137A3 (en) Tablets containing ambroxol
NO2010004I1 (en) 0.02 mg of ethinylostradiol (as betadexclathrate) and 3mg drospirenone
AR033467A1 (en) COMPRESSED MELOXICAM DE RAPIDA DISGREGACION
DK1202996T3 (en) Titanium compounds, manufacture and use thereof
DK1214302T3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones and their use as lipase inhibitors
EE05384B1 (en) Broad-spectrum Á2- (Substituted Áamino) Benzoxazole Sulphonamides ÁkuiÁHIVÁProtease Inhibitors, Use, Pharmaceutical Formulations, and Method for Inhibiting Antiretroviral Replication
NO20034524L (en) 5-membered heterocycles, preparation and use thereof as MAO inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as drugs.

Legal Events

Date Code Title Description
FB Suspension of granting procedure